Vertex stock

[copyman]

anyone know why the vertex stock price is going down even though there have been some good news about telaprevir of late? I wonder if it has something to do with buying that other company. Oh well hopefully good news later this month from the meeting in Copahagen and it will go back up.

[l-horn]

Yeah but if you held Schering-Plough you just made a bunch-o-money last week as they were bought by Merck.

[frijole]

It's called dilution.  Three times in the past maybe two years, the company has diluted the stock.  That is, they have sold new shares.  Twice, to the open market, and this last time they traded money and stock for a company they acquired. To me these aren't bad things, but they do decrease the per share value.

Each time they sold new shares it was to increase revenue for research.  So, the money is being used to get the bugs out of the product -- hopefully that means get rid of the element that causes the severe rashing.

This last time -- the company purchased also has a Hep C drug being tested.  It could be argued they bought them out to get rid of the competition,  but I  have read that they are hopeful this purchase could add to their research -- adding a new compound to the mix.

If you are in for the long run, it is still probably a good buy. Maybe you could watch it and just buy at the beginning of the run up -- which hopefully will come when Telaprevir hits the market.   --- Ha ha - I have hedged my bet and bought shares of both Vertex and Schering Plough (Boceprevir)

frijole

[Rockerforlife]

Boceprevir....thats all ill say.

[copyman]

Vertex = CURE in just 24 weeks!  Thats all I'll say.  

[GoofyDad]

politicians castigating pharma...

Whoa! And I thought that episode with the pages was bad.....this sounds worse.

[Andiamo1]

Vertex is up big time after the EASL release.  It looks more potent than Boceprevir.  The results from Prove 3 are outstanding for people that relapsed.